Your browser doesn't support javascript.
loading
Correction: SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/ß-catenin signaling.
Rong, Zhuoxian; Zhang, Lu; Li, Zhi; Xiao, Zhi; Duan, Yumei; Ren, Xinxin; Zi, Yuyuan; Gao, Jie; Mu, Yun; Guan, Yidi; Cao, Zhen; Wang, Xitao; Pei, Qian; Zeng, Yu; Fan, Qi; Zeng, Zimei; Ou, Danmin; He, Jiang; Nie, Yingjie; Tan, Rong; Weng, Liang; Li, Yuhao; Xiang, Rong; Deng, Yuezhen; Sun, Lunquan.
Afiliação
  • Rong Z; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zhang L; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.
  • Li Z; Institute of Gerontological Cancer Research, National Clinical Research Center for Gerontology, Changsha, 410008, China.
  • Xiao Z; Hunan International Science and Technology Collaboration Base of Precision Medicine for Cancer, Changsha, 410008, China.
  • Duan Y; Center for Molecular Imaging of Central South University, Xiangya Hospital, Changsha, 410008, China.
  • Ren X; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zi Y; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.
  • Gao J; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Mu Y; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.
  • Guan Y; Institute of Gerontological Cancer Research, National Clinical Research Center for Gerontology, Changsha, 410008, China.
  • Cao Z; Hunan International Science and Technology Collaboration Base of Precision Medicine for Cancer, Changsha, 410008, China.
  • Wang X; Center for Molecular Imaging of Central South University, Xiangya Hospital, Changsha, 410008, China.
  • Pei Q; Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zeng Y; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Fan Q; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zeng Z; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.
  • Ou D; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • He J; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.
  • Nie Y; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Tan R; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.
  • Weng L; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Li Y; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.
  • Xiang R; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Deng Y; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.
  • Sun L; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.
Oncogene ; 41(27): 3585, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35701535
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article